LeonaBio, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2017-11-01: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-10-27; Total offering amount $17,000,000.
- 2017-04-20: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-10-27; Total offering amount $11,000,000.
- 2015-11-20: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-10-27; Total offering amount $8,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2017-11-01 D/A | Rule 506(b) | Equity | 2015-10-27 | $17,000,000 | $14,115,000 | $2,885,000 | 41 |
| 2017-04-20 D/A | Rule 506(b) | Equity | 2015-10-27 | $11,000,000 | $10,073,475 | $926,525 | 34 |
| 2015-11-20 | Rule 506(b) | Equity | 2015-10-27 | $8,000,000 | $3,500,000 | $4,500,000 | 10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |